Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 02:05 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Cri Analog PG1 Effectiveness and Safety in Covid-19
NCT04536363 · Alonso Vera Torres · PHASE2 · withdrawn · last registry update 2023-09-15 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Delays in approval by the national regulatory authority” | – | Registry record, Alonso Vera Torres |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against PTGER1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2024-09-03Results posted on the registry: Mayo Clinic, a drug against PTGER1 (NCT04720053)
- 2024-08-28Also stopped (terminated): University Hospital, Limoges, Dinoprostone + Oxytocine (NCT02888041)
- 2024-08-15Results posted on the registry: Centre Hospitalier Departemental Vendee, Dinoprostone (NCT02649920)
- 2024-08-15Also stopped (terminated): Centre Hospitalier Departemental Vendee, Dinoprostone (NCT02649920)
- 2024-07-31Phase 3 first posted: National University Hospital, Singapore, Menopausal hormone therapy + Menopausal hormone therapy + exercise training (NCT06530459)
- 2024-07-19Results posted on the registry: Columbia University, Misoprostol (NCT03670836)
- 2023-09-15Also stopped (suspended): Guangzhou Women and Children's Medical Center, Induction of labor with PGE2 (NCT04780269)
- 2023-08-30Results posted on the registry: Ruth M. Rothstein CORE Center, Lubiprostone (NCT01839734)
- 2023-06-01Results posted on the registry: Henry Ford Health System, lubiprostone (Amitiza) + Placebo (NCT00645801)
- 2023-05-15Also stopped (terminated): University Hospital, Toulouse, Balloon catheter + oral misoprostol + Oral misoprostol alone (NCT03435458)
- 2023-03-17Phase 3 first posted: Hospital Universitario 12 de Octubre, Vaginal dinoprostone (NCT05774236)
- 2023-03-14Phase 3 first posted: Helwan University, Lubiprostone 24Mcg Oral twice daily (NCT05768334)
- 2023-03-09Phase 3 first posted: Beni-Suef University, Dinoprostone + Misoprostol (NCT05761418)
- 2023-02-08Also stopped (terminated): The Hospital for Sick Children, Alprostadil 5 MCG Injection (NCT04054115)
- 2022-11-14Also stopped (terminated): South Warwickshire NHS Foundation Trust, 10 mg Dinoprostone; CTS, UK + 3 mg Dinoprostone vaginal tablet; Pfizer, UK (NCT02956785)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision